Project Grant R01AI187991
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$534K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $562,500.00 to The Salk Institute for Biological Studies to investigate the functions of specialized intestinal T cells, called intraepithelial lymphocytes (IELs), that are recruited to the mammary gland during lactogenesis. The goal is to understand how these entero-mammary IELs promote maternal-offspring...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,260 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Virginia (UVA). The 5-year grant, active from March 1, 2025 to February 28, 2030, supports research to characterize the systemic and mucosal immune response to adenovirus 40/41 infection in Bangladeshi children. The grant has two key objectives: 1) Describe the antibody repertoire to adenovirus 40/41 in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $479,730 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin - Madison. The 5-year grant, effective from December 1, 2024 to November 30, 2029, will support research to elucidate the mechanisms by which prophages (viral DNA) in the gut symbiont Limosilactobacilus reuteri modulate the production of the antimicrobial compound reuterin. The research aims to...
This federal Project Grant award of $508,500.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a study titled "BREATH - Breastfeeding, Early-Life Microbiome and Respiratory Health Study" at New York University School of Medicine. The research aims to elucidate the intricate relationships between breastfeeding, infant microbiome development, and early-life respiratory health...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $569,210 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado Boulder. The grant will fund research to structurally and functionally characterize three key proteins responsible for resistance to cationic antimicrobial peptides (CAMPs) and the antibiotic colistin in gram-negative bacteria. The research aims to close knowledge gaps around the biochemical...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $451,000.00 to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the molecular mechanisms of signal transduction by the Campylobacter jejuni BumSR two-component system. The research aims to determine how this bacterial sensor phosphatase system senses and responds to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $232,415 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. The goal of this 2-year award, with a period of performance from November 2024 to October 2026, is to develop a highly potent monoclonal antibody that can neutralize the cytomegalovirus (CMV)-encoded interleukin-10 (IL-10) protein, in order to prevent primary CMV infection and reduce the...
This $114,976 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research conducted by Seattle Children's Research Institute to elucidate the function of T cells present in breastmilk and their potential role in protecting infants against respiratory infections. The key objectives are to: 1) investigate the transcriptional and clonal overlap between T cells in the lactating breast and upper...
The University of Georgia Research Foundation was awarded a $540,193 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 12-month award, effective August 22, 2023, supports research to investigate the role of calcium-binding proteins and other secretory pathway components in the exocytosis of organelles critical for the invasion and egress of the malaria parasite Plasmodium falciparum...
This $926,057 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research is supporting research to understand how the gut microbiota influences immune responses, particularly B-cell development and antibody production, following vaccination. The project aims to identify gut stromal cell populations and microbial components that are crucial for enhancing stromal cell function and promoting improved...